Study guide
23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents
IJCAHPO Certified Ophthalmic Medical Technologist COMT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements
1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification
2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology
2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway
3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety
3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety
4 Chapter 4: Ophthalmic History Taking & Clinical Documentation
4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record
5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision
5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction
6 Chapter 6: Tonometry, Keratometry & Pupil Measurement
6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria
7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis
7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment
8 Chapter 8: Refraction, Retinoscopy & Refinement
8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations
9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics
9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations
10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy
10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training
11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation
11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing
12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique
12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics
13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols
13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials
14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)
14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics
15 Chapter 15: Fluorescein Angiography Principles & Technique
15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management
16 Chapter 16: Angiographic Interpretation & Pathology
16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology
17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography
17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers
18 Chapter 18: Ophthalmic Photography & Videography
18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management
19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)
19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging
20 Chapter 20: Biometry, Topography & Corneal Analysis
20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth
21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting
21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems
22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications
22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis
23 Chapter 23: Ocular Pharmacology
23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF
24 Chapter 24: Microbiology & Ocular Specimen Collection
24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection
25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery
25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs
26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery
26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol
27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures
27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)
28 Chapter 28: Ophthalmic Patient Services & Education
28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support
29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance
29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements
23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents
Key Takeaways Explain This Topic AI
Phenylephrine dilates the pupil by stimulating the iris dilator and has no cycloplegic effect.
Tropicamide, cyclopentolate, homatropine, scopolamine and atropine are antimuscarinics that both dilate and cycloplege, in increasing order of duration.
Phenylephrine 10% carries a risk of hypertensive crisis and is avoided in cardiovascular disease; 2.5% is the routine strength.
Proparacaine and tetracaine are topical anaesthetics for diagnostic use only; they must never be dispensed for pain relief.
Repeated topical anaesthetic use causes epithelial toxicity, delayed healing and can lead to corneal melting.
Last updated: September 2026
Two ways to dilate a pupil
The iris has two muscles with opposing innervation, so there are two pharmacologic routes to mydriasis.
Sympathomimetics stimulate the dilator muscle:
- Drug Strength Onset / duration Notes
- Phenylephrine 2.5% routine, 10% rarely 20–30 min / 3–5 h No cycloplegia ; also blanches conjunctival vessels
- Hydroxyamphetamine 1% — Diagnostic use in Horner syndrome localisation
- Apraclonidine 0.5–1% — Reverses the miosis of Horner syndrome (diagnostic); also lowers pressure
Antimuscarinics (parasympatholytics) block the sphincter and the ciliary muscle , so they produce both mydriasis and cycloplegia :
- Drug Strength Onset Duration Typical use
- Tropicamide 0.5–1% 15–20 min 4–6 h Routine dilation; weak cycloplegic
- Cyclopentolate 0.5–2% 20–30 min 6–24 h Paediatric cycloplegic refraction
- Homatropine 2–5% 30–60 min 1–3 days Uveitis cycloplegia
- Scopolamine (hyoscine) 0.25% 20–30 min 3–7 days Uveitis
- Atropine 0.5–1% 30–40 min 7–14 days Deep cycloplegia; uveitis; amblyopia penalisation
The routine dilation combination is tropicamide 1% plus phenylephrine 2.5% , which uses both mechanisms and gives a wider, faster dilation than either alone.
Phenylephrine safety
Phenylephrine 10% is a potent alpha-1 agonist and has been associated with hypertensive crisis, tachycardia, arrhythmia, myocardial infarction and subarachnoid haemorrhage after topical ocular use, particularly with repeated instillation, in infants, in the elderly and in patients on monoamine oxidase inhibitors or tricyclic antidepressants.
Practical rules: use 2.5% for routine dilation; avoid 10% in cardiovascular disease, uncontrolled hypertension, aneurysm, thyrotoxicosis and in infants; never instil onto an abraded cornea (absorption rises sharply); apply punctal occlusion; and record the strength used.
Phenylephrine in children: use the lowest effective concentration. 2.5% is standard, and 10% is generally avoided in infancy.
Contraindications and cautions for dilation
Narrow anterior chamber angle — assess anterior chamber depth before dilating. A patient with a shallow chamber, a history of haloes and brow ache, or previously documented narrow angles must be assessed by the clinician first. Acute angle closure after dilation is uncommon but real.
Iris-supported intraocular lens or anterior chamber lens — the clinician should direct.
Known allergy to the agent or its preservative.
Recent trauma with a suspected open globe — instil nothing.
Patients who must drive — warn about photophobia and near blur, advise sunglasses, and confirm arrangements.
Neurological monitoring — pupil size is a neurological observation; check before dilating a patient under head injury observation.
Counselling every dilated patient: blurred near vision and light sensitivity for several hours (longer with cyclopentolate, days with atropine), sunglasses, no driving until vision is comfortable, and to return immediately for severe pain, redness or haloes.
Topical anaesthetics
- Drug Onset Duration Notes
- Proparacaine (proxymetacaine) 0.5% 10–20 s 10–20 min Least stinging; the routine choice; refrigerate
- Tetracaine (amethocaine) 0.5% 10–20 s 10–20 min More stinging, slightly longer acting
- Oxybuprocaine (benoxinate) 0.4% 10–20 s 10–15 min Often combined with fluorescein
- Lidocaine gel 2% 1–2 min 20–30 min Used before injections and minor procedures
Uses: applanation tonometry, pachymetry, gonioscopy and contact lens examination, foreign body removal, punctal dilation, corneal scraping, and comfort during Schirmer basal secretion testing.
The hard rule: topical anaesthetics are for diagnostic and procedural use in the clinic only and are never dispensed to a patient for pain relief . Repeated use causes:
- Epithelial toxicity and punctate keratopathy
- Delayed epithelial healing — the drug is directly toxic to migrating epithelial cells
- Loss of corneal sensation , removing the protective blink and the warning of further injury
- Neurotrophic ulceration, stromal melting and perforation in chronic abuse
- Ring infiltrates that mimic Acanthamoeba keratitis
Anaesthetic abuse is a recognised and serious clinical entity, usually arising when a patient obtains a bottle after a painful abrasion. Always warn the patient that the anaesthetic will wear off and that the eye must not be rubbed while it is numb.
Diagnostic agents
Agent Use Key points
Sodium fluorescein (strips or drops) Epithelial defects, applanation, Seidel test, tear break-up time, contact lens fitting Stains soft contact lenses — remove them first; use the cobalt blue filter
Intravenous fluorescein Fluorescein angiography Causes transient yellowing of skin and bright yellow urine for 24 to 36 hours — warn the patient; nausea is common; anaphylaxis is rare but possible
Lissamine green Devitalised cells, mucin-deficient epithelium Well tolerated; view 1 to 4 minutes after instillation
Rose bengal Same targets as lissamine green Stings considerably; largely superseded
Indocyanine green Choroidal angiography Contains iodine — contraindicated in iodine or shellfish allergy and in significant liver disease
- Trypan blue Capsule staining in white cataract surgery Intraoperative
- Reversal and related agents
There is no reliable routine reversal agent for pharmacologic mydriasis in common clinical use, so the correct answer to "can you undo this dilation?" is to explain the expected duration rather than to instil a miotic. Pilocarpine will constrict a pharmacologically dilated pupil only partially and introduces its own effects, and it is not used routinely for this purpose.
Apraclonidine is used diagnostically : in Horner syndrome the denervated dilator is supersensitive, so apraclonidine reverses the anisocoria , dilating the smaller pupil — a useful confirmatory test. Cocaine 4% blocks noradrenaline reuptake and fails to dilate a Horner pupil; hydroxyamphetamine 1% dilates a pre-ganglionic but not a post-ganglionic Horner pupil, localising the lesion.